**Exploring Temple’s FDA Legacy, Chinese Biotech Innovation, and Novo Nordisk’s Obesity Data – A BioCentury Podcast** The biopharmaceutical industry is...

**Exploring a Unique Collection Addressing Challenges Through Interdisciplinary Approaches** In an increasingly complex and interconnected world, the challenges we face...

# Understanding Supra-Thermal Ions in Inertial Systems: Key Insights and Mechanisms In the realm of plasma physics and inertial confinement...

# Key Medical Breakthroughs and Innovations of 2024 The year 2024 has proven to be a landmark period for medical...

# Top Six Biotech Companies Driving Innovation in India India has emerged as a global hub for biotechnology, leveraging its...

# Production, Purification, and Biological Activity Assessment of Recombinant Tilapia Lake Virus Segment 4 Protein for Vaccine Development ## Introduction...

**Impact of Initial Glucose Levels on Vidal Grape Juice Fermentation Efficiency in Ice Wine Production** Ice wine, a luxurious and...

**Lactoferrin Inhibits Hepatocellular Carcinoma Progression by Targeting INTL1 Receptor and Modulating Apoptosis and Cell Cycle Pathways** Hepatocellular carcinoma (HCC) is...

# Dynamic Transcriptomics Reveals Coordinated Transcriptional Regulation of Artemisinin and Phenylpropanoid Biosynthesis Pathways in *Artemisia annua* Under Cold Stress ##...

# Exploring the Role and Impact of Natural Killer Cells [Rebroadcast] Natural Killer (NK) cells are a fascinating and essential...

# Exploring the Role and Impact of Natural Killer Cells The human immune system is a complex and highly coordinated...

**Utilizing Stem Cell Membrane Antigens for Immune System Applications** The field of regenerative medicine and immunotherapy has witnessed remarkable advancements...

**Development of a Fully Automated SIMPLE RPA Microfluidic Chip for In Ovo Sex Determination** The poultry industry is a cornerstone...

**How Biotechnology is Turning Christmas Miracles into Reality** The holiday season is a time of wonder, joy, and the occasional...

**How Biotech Innovations Are Turning Christmas Miracles Into Reality** The holiday season is a time of wonder, joy, and hope—a...

# CAR T Cells: A Festive Parody Song Celebrated on the *Nature* Podcast In the world of science communication, creativity...

**CAR T Cells: A Festive Parody Song Featured on the Nature Podcast** In the world of science communication, creativity often...

**CAR T Cells Explained: A Festive Parody Song from the Nature Podcast** In the world of cutting-edge medical science, few...

**Exploring CAR T Cells Through a Festive Parody Song on the Nature Podcast** In the ever-evolving world of science communication,...

**James Wilson’s GEMMABio Raises $34 Million to Propel Gene Therapy Innovations** In a significant milestone for the field of gene...

**GEMMABio Raises $34 Million Under James Wilson’s Leadership to Propel Gene Therapy Innovations** In a groundbreaking development for the biotechnology...

**FDA Approves Vertex Drug for Treating Cystic Fibrosis: A Breakthrough in Precision Medicine** In a landmark decision that underscores the...

**Serum-Free Conditioned Medium Enables Adhesion and Growth of Bovine Myogenic Cells on Uncoated Surfaces** The field of cellular agriculture has...

# Mathematical Modeling of Ligand Inter-Nanocluster Connectivity Using Modularity to Decipher Reversible Stem Cell Regulation Stem cells are the cornerstone...

**Serum-Free Conditioned Culture Medium Enables Adhesion and Growth of Bovine Myogenic Cells on Uncoated Surfaces** The field of cellular agriculture...

**Optimized Linker in Bispecific Antibody Enhances Blood-Brain Barrier Transcytosis via TfR in Vitro** The blood-brain barrier (BBB) is a highly...

# Development of a Mirror-Image Monobody Targeting MCP-1 Using TRAP Display and Chemical Protein Synthesis The development of therapeutic agents...

**Immunomagnetic Purification of Multi-Receptor CAR T Cells Using Leucine Zipper Technology** Chimeric Antigen Receptor (CAR) T cell therapy has revolutionized...

“Engineering Escherichia coli for Optimized Fermentation Conditions in Whole-Cell Catalytic Synthesis of D-Allulose”

# Engineering *Escherichia coli* for Optimized Fermentation Conditions in Whole-Cell Catalytic Synthesis of D-Allulose

## Introduction

D-Allulose, also known as D-psicose, is a rare sugar with approximately 70% of the sweetness of sucrose but only 0.3% of its caloric value. It has gained significant attention in the food and pharmaceutical industries due to its health benefits, including anti-obesity, anti-diabetic, and antioxidant properties. However, the natural abundance of D-allulose is extremely low, making its large-scale production challenging. Biotechnological approaches, particularly microbial whole-cell catalysis, have emerged as a promising solution for the cost-effective and sustainable synthesis of D-allulose. Among microbial hosts, *Escherichia coli* has been widely used due to its well-characterized genetics, rapid growth, and ease of genetic manipulation. This article explores the engineering of *E. coli* for optimized fermentation conditions to enhance the whole-cell catalytic synthesis of D-allulose.

## The Role of Whole-Cell Catalysis in D-Allulose Production

Whole-cell catalysis involves using living microbial cells as biocatalysts to convert substrates into desired products. In the case of D-allulose production, the key reaction is the isomerization of D-fructose to D-allulose, catalyzed by D-allulose 3-epimerase (DAE). Whole-cell systems offer several advantages over purified enzyme systems, including reduced production costs, enzyme stabilization within the cellular environment, and the ability to regenerate cofactors if required.

However, the efficiency of whole-cell catalysis depends on several factors, including the expression level of the target enzyme, substrate uptake, intracellular metabolic balance, and fermentation conditions. Engineering *E. coli* to optimize these factors is critical for achieving high yields of D-allulose.

## Strategies for Engineering *E. coli* for D-Allulose Production

### 1. **Heterologous Expression of D-Allulose 3-Epimerase**
The first step in engineering *E. coli* for D-allulose production is the introduction of a gene encoding DAE. This enzyme is typically derived from thermophilic or mesophilic microorganisms such as *Clostridium cellulolyticum*, *Agrobacterium tumefaciens*, or *Flavonifractor plautii*. To achieve high expression levels, strong promoters (e.g., T7 or lac promoters) and optimized ribosome binding sites are used. Codon optimization is also performed to ensure efficient translation in *E. coli*.

### 2. **Improving Substrate Uptake and Transport**
Efficient uptake of D-fructose, the substrate for D-allulose synthesis, is essential for high catalytic activity. Native *E. coli* transporters, such as the phosphotransferase system (PTS), can be engineered to enhance D-fructose uptake